Back

Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome

28 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Antithrombotic therapy in acute coronary syndromes and PCI Anticoagulants ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mattia Galli

Sapienza University of Rome, Rome (Italy)

6 More presentations in this session

Presentation thumbnail
Pharmacodynamic and pharmacokinetic profiles associated with switching from cangrelor to prasugrel in patients undergoing percutaneous coronary intervention: the SWAP-6 study
Doctor M. Galli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
Doctor A. Lai (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Repeat coronary revascularization in high-risk patients treated with ticagrelor monotherapy after PCI: Insights from the randomized TWILIGHT trial
Professor R. Mehran (New York City, US)
Abstract Slides Video
Presentation thumbnail
In vitro comparison of platelet aggregation between zalunfiban and selatogrel in healthy donors
Mr S. Rikken (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Ticagrelor or clopidogrel in atrial fibrillation patients undergoing percutaneous coronary intervention for myocardial infarction
Doctor S. Godtfredsen (Aalborg, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic therapy in acute coronary syndromes and PCI

The Event

Event poster

ESC Congress 2023

28 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources